BAYER AG

To advance food security, partnerships should focus on reducing agriculture's environmental impact, adapting to climate change, and providing affordable solutions to 600mn smallholder farmers. Rice, a key food commodity, contributes significantly to climate change and water consumption. Bayer and IRRI introduced the direct-seeded rice (DSR) system to reduce emissions and water use by up to 45% and 40%, respectively, aiming to improve water use efficiency by 25% by 2030, benefiting smallholder farmers in India.

AskBio's AB-1003 (LION-101) received rare pediatric and orphan drug designations from the FDA for treating limb-girdle muscular dystrophy type 2I/R9 (LGMD2I/R9), highlighting the significant unmet need in LGMD. LGMD2I/R9, caused by FKRP gene changes, leads to muscle weakness and wasting, with no current treatment modifying disease progression. AskBio aims to develop AAV-based therapies for debilitating diseases.

Bayer's MEDRAD Centargo CT Injection System, cleared by the FDA, enhances workflow efficiency in high-volume CT suites, addressing the US radiology technologist shortage. Launched in 2020 and available in 49 markets, it integrates with Bayer’s portfolio, optimizing contrast usage and connectivity. Designed for quick setup and patient line changes, it includes features like Dual Flow and prevents cross-contamination. Bayer, with over 100 years in radiology, continues to innovate with AI and medical imaging solutions.

Bayer received FDA 510(k) clearance for its MEDRAD Centargo CT injection system, designed to enhance workflow efficiency in high-volume CT suites. The system, used by 7 million patients in 49 markets since 2020, reduces patient set-up time, integrates barcode reader for streamlined data entry, and features Dual Flow technology. Sunnybrook Health Sciences Centre in Toronto was the first North American hospital to adopt it, noting improved technologist efficiency and patient interaction. The system also won the Red Dot Design Award 2020 and an AmeriStar Award for innovative packaging.

Bayer's MEDRAD Centargo CT Injection System, approved by the FDA, offers multi-patient use, quick setup, and automated features, enhancing workflow efficiency and patient interaction.

Matica Biotechnology developed a high-resolution AAV8 capsid analysis method, Kincell Bio appointed Stewart McNaull as Chief Commercial Officer, and Ensoma launched in vivo hematopoietic stem cell engineering programs for genetic, immune, and cancer-related diseases.

Bayer's MEDRAD® Centargo CT Injection System, cleared by the FDA, enhances workflow efficiency in radiology departments, addressing the shortage of technologists and rising imaging demand.

AskBio receives FDA rare pediatric disease and orphan-drug designations for AB-1003, targeting limb-girdle muscular dystrophy type 2I/R9, acknowledging significant unmet medical need and supporting efforts to bring a new therapeutic option to patients.